Aprameya Pharmachem Private Limited
About Aprameya Pharmachem Private Limited
Data last updated:
Aprameya Pharmachem Private Limited is a private limited company based in Ahmedabad, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 08 November 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24239GJ2019PTC110736. Its GSTIN is 24AASCA9160A1ZR (Gujarat).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Shibani Deepak Anklesaria and Deepak Asvin Anklesaria.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Office No. 614 Shivalik Satyamev Near Bopal Junction Ambli – Bopal Road, Ahmedabad, Gujarat, India – 380058.
As per the financials filed for FY 2024, the company reported a revenue of ₹129.81 Cr, a growth of 56% compared to the previous year. For the same year it recorded a net profit of ₹65.56 Lakh (net margin 0.5%) and EBITDA of ₹95.34 Lakh (EBITDA margin 0.7%). Revenue has grown at a compounded annual rate (CAGR) of 74% over three years.
The company has 3 deals on record (3 secondary share transfers); the latest was in March 2024. Its 7 peer companies in the Healthcare industry (Healthcare Equipment Retail and Distribution), with the same principal business activity (wholesale trading) are compared by revenue, 4 larger and 3 smaller; the largest is Kci Medical India Private Limited with revenue of ₹136.29 Cr.
Company details
Contact details
Aprameya Pharmachem Private Limited's registered office is in Ahmedabad, Gujarat. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressOffice No. 614 Shivalik Satyamev Near Bopal Junction Ambli – Bopal Road, Ahmedabad, Gujarat, India – 380058
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Aprameya Pharmachem Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Aprameya Pharmachem is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Aprameya Pharmachem Private Limited, buy the company report.
Financials of Aprameya Pharmachem Private Limited
FY 2024 filings availableAprameya Pharmachem Private Limited reported revenue of ₹129.81 Cr (up 56% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 74% over three years, including 56% growth in the latest year. EBITDA rose 13% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹95.34 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹65.56 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.7% | ||||
| Net Profit Margin | 0.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Aprameya Pharmachem Private Limited, buy the company report.
Board of directors of Aprameya Pharmachem Private Limited
Aprameya Pharmachem has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shibani Deepak Anklesaria | Director | 08 Nov 2019 | 6 Years 11 Months | Current |
| Deepak Asvin Anklesaria Also directs: Champ Air Transport Private Limited | Director | 08 Nov 2019 | 6 Years 11 Months | Current |
| Jay Dipakbhai Thakkar | Director | 21 Apr 2023 | 3 Years 6 Months | Current |
Peer comparison
Aprameya Pharmachem Private Limited is compared with the 7 companies closest to it by revenue in the Healthcare industry (Healthcare Equipment Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Kci Medical India Private Limited | ₹136.29 Cr (FY 2025) | 148.0% | New Delhi, Delhi, India | |||
| Erbe Medical India Private Limited | ₹135.81 Cr (FY 2025) | 26.0% | New Delhi, Delhi, India | |||
| Sartorius India Private Limited | ₹134.4 Cr (FY 2025) | 8.0% | Bangalore, Karnataka, India | |||
| Abbott Diagnostics Medical Private Limited | ₹134.36 Cr (FY 2025) | -8.0% | New Delhi, Delhi, India | |||
| Aprameya Pharmachem Private Limitedthis company | ₹129.81 Cr (FY 2024) | ₹65.56 Lakh | 0.5% | 56.0% | Ahmedabad, Gujarat, India | |
| Findoc Ventures Private Limited | ₹128.66 Cr (FY 2025) | -46.0% | Ludhiana, Punjab, India | |||
| Sampatti New Life Private Limited | ₹127.6 Cr (FY 2025) | 20.0% | Mumbai, Maharashtra, India | |||
| Cordis India Medical Devices Private Limited | ₹125.92 Cr (FY 2025) | 31.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Aprameya Pharmachem Private Limited, buy the company report.
Auditor
Aprameya Pharmachem Private Limited is audited by Sahil Padsala for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Sahil Padsala | FY 2023 | 149389 |
Shareholding
The shareholding of Aprameya Pharmachem Private Limited is on record for 4 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Aprameya Pharmachem Private Limited, buy the company report.
Deals & funding
Aprameya Pharmachem Private Limited has 3 deals on record (3 secondary share transfers); the latest was in March 2024.
Deals on record (3 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2024 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: an individual |
| Jul 2023 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: an individual |
| Mar 2023 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: an individual |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Aprameya Pharmachem Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Aprameya Pharmachem Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Aprameya Pharmachem has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AASCA9160A1ZR | Gujarat | Active | 08 Nov 2019 |
To see the full GST registrations and return filing status of Aprameya Pharmachem Private Limited, buy the company report.
Recent activity
Aprameya Pharmachem Private Limited has 3 board changes on record since 2019: 3 appointments. The latest: Jay Dipakbhai Thakkar was appointed as Director on 21 Apr 2023.
Frequently asked questions
Aprameya Pharmachem is an active private limited company based in Ahmedabad, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 08 November 2019 (7+ years old) and is registered under CIN U24239GJ2019PTC110736.
Aprameya Pharmachem has 3 current directors:
- Shibani Deepak Anklesaria - Director
- Deepak Asvin Anklesaria - Director
- Jay Dipakbhai Thakkar - Director
The latest financial statements of Aprameya Pharmachem on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Aprameya Pharmachem is 24AASCA9160A1ZR, registered in Gujarat.
The CIN (Corporate Identification Number) of Aprameya Pharmachem is U24239GJ2019PTC110736. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aprameya Pharmachem was incorporated on 08 November 2019, making it 7+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Aprameya Pharmachem has 3 deals on record (3 secondary share transfers); the latest was in March 2024.
The peers of Aprameya Pharmachem by revenue are Kci Medical India Private Limited, Erbe Medical India Private Limited, Sartorius India Private Limited, Abbott Diagnostics Medical Private Limited, Findoc Ventures Private Limited and 2 more, all in the Healthcare industry (Healthcare Equipment Retail and Distribution), with the same principal business activity (wholesale trading).
Jay Dipakbhai Thakkar was appointed as Director on 21 Apr 2023. Deepak Asvin Anklesaria was appointed as Director on 08 Nov 2019. Shibani Deepak Anklesaria was appointed as Director on 08 Nov 2019.
The registered office of Aprameya Pharmachem is at Office No. 614 Shivalik Satyamev Near Bopal Junction Ambli – Bopal Road, Ahmedabad, Gujarat, India – 380058.
Aprameya Pharmachem operates in the pharma industry, in the drug formulation and development segment.